GlobeNewsWire
28 Sept 2026, 05:00 UTC · 8h ago
Verdict
Headline takes no side. We score ADXN +0.40 across four claims — moderately bullish.
+0.40moderately bullish
More positive than 67% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish · 4 new · 0 priced in
Addex sold 52,970,533 shares between July 1 and August 25, 2026, for gross proceeds of CHF 2.3 million.
Newannouncement dated September 28, 2026
So whatThe cash injection increases the H1 cash balance of CHF 0.8 million to approx. CHF 3.1 million, extending the runway for the GABAB cough program.
More positive than 93% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
The spin-out company Neurosterix is on track to complete its Phase 1 clinical study with NTX-253 during the fourth quarter of 2026.
Newannouncement dated September 28, 2026
More positive than 79% of claims this week
Addex regained all rights to the GABAB PAM program for substance use disorders from Indivior.
Newannouncement dated September 28, 2026
More positive than 66% of claims this week
Cash and cash equivalents decreased to CHF 0.8 million at June 30, 2026, from CHF 2.3 million a year prior.
Newannouncement dated September 28, 2026
So whatThe CHF 1.5 million YoY drop highlights a precarious liquidity position that necessitated the emergency share sale in July/August.
More negative than 77% of claims this week
Which stocks this story touches
More positive than 67% of ticker scores this week
Successfully raised $2.8 million and regained rights to a valuable GABAB PAM program, despite a slight increase in net loss.
More negative than 62% of ticker scores this week
The company is rationalizing its R&D and returning rights to a drug program following a merger.
Near neutral — 92% of ticker scores this week are stronger
Mentioned in the context of a merger with Indivior, but no specific positive or negative outcome is detailed for its own performance.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
4h ago
More positive than 35% of relationship scores this week
[mutual] Addex regained all rights to a GABAB PAM program previously held by Indivior.
—
ADXN hasn't traded since this ran. Last close $3.65 (Sep 25); the reaction starts at the next open.
ADXN chart →
